Susan Iliff
Overview
Explore the profile of Susan Iliff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim R, Chang J, Lins A, Brady E, Candelore M, Dallas-Yang Q, et al.
Bioorg Med Chem Lett
. 2008 Jun;
18(13):3701-5.
PMID: 18539028
The discovery and optimization of potent and selective aminobenzimidazole glucagon receptor antagonists are described. One compound possessing moderate pharmacokinetic properties in multiple preclinical species was orally efficacious at inhibiting glucagon-mediated...
2.
Schroder C, Pierson 3rd R, Nguyen B, Kawka D, Peterson L, Wu G, et al.
J Immunol
. 2007 Aug;
179(4):2289-99.
PMID: 17675490
Pharmacologic antagonism of CCR5, a chemokine receptor expressed on macrophages and activated T cells, is an effective antiviral therapy in patients with macrophage-tropic HIV infection, but its efficacy in modulating...
3.
Shen Z, Bakhtiar R, Komuro M, Awano K, Taga F, Colletti A, et al.
Rapid Commun Mass Spectrom
. 2005 Mar;
19(9):1125-9.
PMID: 15799073
MK-0767, (+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide, is a thiazolidinedione-containing dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist that has been studied as a potential treatment for patients with type 2 diabetes. MK-0767 contains a chiral...